Loading clinical trials...
Loading clinical trials...
Observe the Safety and Effectiveness of the WATCHMAN FLX™ Left Atrial Appendage Closure (LAAC) Device for Subjects With Non-valvular Atrial Fibrillation to Reduce the Risk of Stroke in Hong Kong Area
Conditions
Interventions
The WATCHMAN FLX Delivery System
Locations
1
China
Queen Mary Hospital
Hong Kong, China
Start Date
June 19, 2020
Primary Completion Date
January 24, 2022
Completion Date
March 28, 2023
Last Updated
August 12, 2024
NCT04559243
NCT05565599
NCT06606275
NCT05022758
NCT03515083
NCT02954237
Lead Sponsor
Boston Scientific Corporation
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions